This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Add RenaissanceRe to Your Portfolio
by Zacks Equity Research
RenaissanceRe (RNR) holds potential to provide benefits to investors on the back of its growing premiums and financial strength.
Here's Why Should You Hold onto Everest Re (RE) Stock Now
by Sapna Bagaria
Everest Re (RE) is poised to benefit from high premium growth in the reinsurance market as well as a solid capital position.
Everest Re (RE) Down 17.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Everest Re (RE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Everest Re (RE) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Everest Re's (RE) Q4 results gain from better revenues and contribution from its reinsurance and insurance businesses.
Everest Re (RE) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Everest Re (RE) Q4 performance is likely to have benefited from pricing gains in Insurance and Reinsurance lines of business.
Everest Re (RE) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Everest Re (RE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Everest Re (RE) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Everest Re (RE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
TPRE or RE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TPRE vs. RE: Which Stock Is the Better Value Option?
Reasons Why Investors Should Buy Everest Re Group (RE) Stock
by Zacks Equity Research
Everest Re Group (RE) remains poised for growth on higher investment income, solid capital position and financial flexibility.
RenaissanceRe Outshines in 2019: Will the Rally Continue?
by Zacks Equity Research
RenaissanceRe (RNR) holds enough potential to grow in 2020 on its growth initiatives and rising premiums.
Allstate Announces Catastrophe Loss Estimate & Growth Plan
by Zacks Equity Research
Allstate's (ALL) property and casualty business exposes it to catastrophe-related losses.
AXIS Capital (AXS) Boosts Shareholder Value, Hikes Dividend
by Zacks Equity Research
AXIS Capital's (AXS) hikes dividend by 2.5% in an effort to share more profits with its shareholders.
Everest Re (RE) Up 6.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Everest Re (RE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chubb (CB) to Boost Shareholder Value Via Share Buybacks
by Zacks Equity Research
Chubb's (CB) dividend announcement and approval of a share buyback program reflect operational strength, thereby supporting effective capital deployment.
Everest Re (RE) Boosts Shareholder Value, Hikes Dividend
by Zacks Equity Research
Everest Re (RE) hikes dividend by 11%, reflecting capital adequacy and financial flexibility.
Everest Re (RE) Q3 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
Everest Re (RE) Q3 results reflect growth at both its reinsurance and insurance businesses
Everest Re (RE) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Everest Re (RE) delivered earnings and revenue surprises of 63.77% and -0.78%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Everest Re (RE) This Earnings Season?
by Zacks Equity Research
Everest Re (Re) is likely to have gained from solid performance of both the Reinsurance and Insurance segment and lower expenses in the third quarter.
Analysts Estimate Everest Re (RE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Everest Re (RE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Everest Re (RE) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Everest Re (RE) have what it takes? Let's find out.
Everest Re Group (RE) Provides Estimates for Q3 Cat Loss
by Zacks Equity Research
Everest Re (RE) expects cat loss to be $280 million due to Hurricane Dorian and Typhoon Faxai.
Allstate (ALL) Hits 52-Week High: Is Further Upside Left?
by Zacks Equity Research
Allstate's (ALL) strong property liability business, growing service business and sturdy balance sheet will likely aid its stock.
Here's Why You Should Hold Everest Re (RE) in Your Portfolio
by Zacks Equity Research
Everest Re Group (RE) remains poised for growth on risk management ability, capital sufficiency and global presence.
P&C Insurance Industry's Near-Term Prospects Encouraging
by Tanuka De
The property and casualty insurance industry remains well poised on better pricing, solid policyholders' surplus and increasing use of technology.
Insurers in Focus as Concerns Over Hurricane Dorian Loom
by Tanuka De
As Hurricane Dorian devastates causing huge cat loss, we focus on few insurers and reinsurers how the share price moves and impact financial results.